Intermittent maximal androgen blockade in patients with metastatic prostate cancer: an EORTC feasibility study.

Intermittent maximal androgen blockade in patients with metastatic prostate cancer: an EORTC feasibility study.

Item
http://www.wikidata.org/entity/Q44628086
Prolongation of off-cycle interval by finasteride is not associated with survival improvement in intermittent androgen deprivation therapy in LNCaP tumor modelIntermittent versus continuous androgen suppression therapy: do we have consensus yet?Endocrine therapy for prostate cancer.A randomized, phase II study of pazopanib in castrate-sensitive prostate cancer: a University of Chicago Phase II Consortium/Department of Defense Prostate Cancer Clinical Trials Consortium study.Optimizing outcomes and quality of life in the hormonal treatment of prostate cancer.International study into the use of intermittent hormone therapy in the treatment of carcinoma of the prostate: a meta-analysis of 1446 patients.Is hormone ablation still the right choice for advanced prostate cancer?The role of intermittent androgen deprivation in prostate cancer.Recovery of hormone sensitivity after salvage brachytherapy for hormone refractory localized prostate cancer.Prostate cancer in Spain: from guidelines to clinical practice.Comparison of intermittent and continuous androgen deprivation and quality of life between patients with locally advanced and patients with metastatic prostate cancer: a post hoc analysis of the randomized FinnProstate Study VII.
P2860

Intermittent maximal androgen blockade in patients with metastatic prostate cancer: an EORTC feasibility study.

Item
http://www.wikidata.org/entity/Q44628086
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Intermittent maximal androgen ...... r: an EORTC feasibility study.
@en
Intermittent maximal androgen ...... r: an EORTC feasibility study.
@nl
type
label
Intermittent maximal androgen ...... r: an EORTC feasibility study.
@en
Intermittent maximal androgen ...... r: an EORTC feasibility study.
@nl
prefLabel
Intermittent maximal androgen ...... r: an EORTC feasibility study.
@en
Intermittent maximal androgen ...... r: an EORTC feasibility study.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Intermittent maximal androgen ...... r: an EORTC feasibility study.
@en
P2093
P304
P31
P356
10.1016/S0302-2838(03)00375-0
P407
P433
P478
P577
P698
P921